Skip to main content
OpenTrials

Clinical trial condition

Diabetes

Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.

2,489 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Diabetes trial results

Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01068678

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Northridge, California, United States
  • Novo Nordisk Investigational Site Palm Springs, California, United States
  • Novo Nordisk Investigational Site Paramount, California, United States
  • Novo Nordisk Investigational Site Santa Ana, California, United States
View all 99 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01076647

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Peoria, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Beverly Hills, California, United States
View all 105 locations
View Trial Details
Completed

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

NCT01326026

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site La Jolla, California, United States
View all 45 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01068665

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Gilbert, Arizona, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
View all 116 locations
View Trial Details
Completed

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

NCT01388361

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site La Jolla, California, United States
  • Novo Nordisk Investigational Site Lancaster, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
View all 124 locations
View Trial Details
Completed

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

NCT01046110

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Greenbrae, California, United States
View all 93 locations
View Trial Details
Completed

A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)

NCT01868542

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Daejeon, South Korea
  • Novo Nordisk Investigational Site Daejeon, South Korea
  • Novo Nordisk Investigational Site Daejeon, South Korea
  • Novo Nordisk Investigational Site Daejeon, South Korea
View Trial Details
Completed

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

NCT00611884

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Inglewood, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Redlands, California, United States
  • Novo Nordisk Investigational Site Spring Valley, California, United States
View all 29 locations
View Trial Details
Completed

Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes

NCT00841087

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Ebina-shi, Japan
  • Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan
  • Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan
View Trial Details
Completed

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

NCT00612040

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Walnut Creek, California, United States
  • Novo Nordisk Investigational Site Honolulu, Hawaii, United States
  • Novo Nordisk Investigational Site Idaho Falls, Idaho, United States
  • Novo Nordisk Investigational Site Des Moines, Iowa, United States
View all 33 locations
View Trial Details

Related conditions